Cargando…
Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?
The question of whether UK oncologists follow current anthracycline dose modifications when treating patients with liver dysfunction was addressed through a questionnaire. Oncologists were asked the dose of doxorubicin or epirubicin they would prescribe for a woman with breast cancer and liver metas...
Autores principales: | Dobbs, N. A., Twelves, C. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150122/ https://www.ncbi.nlm.nih.gov/pubmed/9569053 |
Ejemplares similares
-
Anthracycline dose and liver dysfunction
por: Cannizzaro, R, et al.
Publicado: (1999) -
What is the effect of adjusting epirubicin doses for body surface area?
por: Dobbs, N. A., et al.
Publicado: (1998) -
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer
por: Munro, A F, et al.
Publicado: (2012) -
Basic MRI for the liver oncologists and surgeons
por: Vu, Lan N, et al.
Publicado: (2018) -
Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
por: Gupta, Ajay
Publicado: (2012)